Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

NCT01720264

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +24 more
Locations: Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

New York Medical College/Westchester Medical Center/Maria Fareri Children's Hosptial Valhalla, New York, United States

View Trial Details

Completed

BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

NCT03794167

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Jong-Ho Won Seoul, South Korea

View Trial Details

Completed

p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

NCT02846935

Conditions: Aggressive B-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

NCT01959282

Conditions: Behavior, Colitis, Colitis, Ulcerative, +17 more
Locations: La Jolla, California, United States

Thornton, Colorado, United States

Ann Arbor, Michigan, United States

Tupelo, Mississippi, United States

View all 97 locations

View Trial Details

Completed

Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL)

NCT03792815

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Soonchunhyang University Hospital Seoul, South Korea

View Trial Details

Completed

Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02391116

Conditions: Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Kingswood, New South Wales, Australia

Ballarat, Victoria, Australia

Prahran, Victoria, Australia

Box Hill, Australia

View all 32 locations

View Trial Details

Completed

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

NCT02240719

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
Locations: University of California Davis Sacramento, California, United States

View Trial Details

Completed

18F-FSPG PET/CT for Cancer Patients on Therapy

NCT02599194

Conditions: Adenocarcinoma, Adenoma, B-Cell Neoplasm, +53 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma

NCT01987505

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Hospital De Txagorritxu; Servicio de Hematologia Vitoria-Gasteiz, Alava, Spain

Hospital General de Elda; Servicio de Hematologia Elda, Alicante, Spain

Hospital Son Llatzer; Servicio de Hematologia Palma de Mallorca, Balearic Islands, Spain

Hospital de Granollers, Servicio de Hematología Granollers, Barcelona, Spain

View all 39 locations

View Trial Details

Completed

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01241591

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations: Centro de Investigaciones Dermatologicas Buenos Aires, C1114aap, Argentina

Centro de Investigaciones Dermatologicas Buenos Aires, Argentina

IMAI (Instituto Medico de Asistencia e Investigaciones) Buenos Aires, Argentina

LKH Feldkirch Abteilung fuer Dermatologie und Venerologie Feldkirch, Austria

View all 122 locations

View Trial Details